Quick Take: The Senator and the Snake Oil

Note to Barack Obama: It's stuff like this that has earned you the moniker "Obambi." (Keep up the speculative investing, and maybe they'll call you "Obooya.")

This New York Times article details a couple of sketchy-looking stock buys that Obama made. He put about $50,000 into some very speculative companies "whose major investors included some of his biggest political donors."

There are more than a few ethical issues to jawbone here, the first of which would seem to be Obama's purchase of AVI Biopharma (Nasdaq: AVII), which was hawking a bird-flu vaccine story, around the same time that the freshly minted Illinois senator began stumping for bird-flu funding on Capitol Hill. It also looks a bit sleazy that he (or his broker, as the excuse goes) was buying stock in companies backed by some of his big political donors.

But here's a bigger issue -- Obama's realization that he owned these companies (and the subsequent sale) even though he had his money in a "blind" trust. How blind is a trust that lets you know what you hold? And why are these guys (senators) allowed to invest in individual stocks anyway, when they wield so much power over funding that can, in some cases, flow directly to these companies? Incredibly, ethics rules allow it.

Those rules ought to be changed. Yesterday. And if Obama wants to be taken seriously as a reformer, maybe he ought to hold himself to a higher standard. How about mutual funds only, Barack? Indexes, even?

The issue is bigger than the dollars involved, which aren't too huge. Obama admits to making a couple grand on AVI. But that would make him one of the lucky ones. This chart shows you how AVI stock fared after the bird-flu mania ran its course.

So it's poetic justice that Obama lost a much bigger pile of money on the second of the lousy stocks, Skyterra Communications (OTC BB: SKYT.OB), which had a hot story about its plans for hybrid satellite/terrestrial communications. Apparently, no one remembers the lesson of Iridium: It's tough to compete with giants like T-Mobile, Vodafone (NYSE: VOD), and AT&T (NYSE: T) when the only differentiator is the promise of communications from places no one wants to be anyway.

It should surprise no one, then, that Obama's satellite stock, a perennial, money-burning loser, has been mauled in the market, despite having been pumped (with the prediction of a triple) by one Tejas Securities. Which leads us down another freaky rabbit hole. Tejas is a subsidiary of yet another bulletin-board-listed company, one that has shed about three-fourths of its stock price over the past two years and posted losses of nearly $50 million for the trailing 12 months ended in September 2006.

And according to that Times article, the chair of Tejas, and affiliates, donated $150,000 to Obama's political committees, in addition to arranging for his use of private planes.

If you're familiar with Illinois politics, none of this will surprise you. (If you're not, John Kass will give you a crash course.) Tidy connections between pols and biz figures are the rule there, not the exception.

The moral of the story? Faces may change, but the story sounds the same.

Oh, and don't bother taking stock tips from Obama or his broker.

Comments? Bring them here.

At the time of publication, Seth Jayson had no positions in any company mentioned here. See his latest blog commentary here. View his stock holdings and Fool profile here. Vodafone is a Motley Fool Inside Value recommendation. AT&T is a former Stock Advisor pick. Fool rules are here

Comment (0)
Recommended (22)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 523499, ~/articles/articlehandler.aspx, 10/11/2008 12:36:54 AM,

Sign up for FREE Motley Fool site access!

Already registered? Login Here

It’s FREE! Enter your email address, and we’ll rush you to the article you're looking for right now.

Privacy / Legal Information

We will use your email address only to keep you informed about updates to our web site and about other products and services that we think might interest you. The Motley Fool respects your privacy. Please read our Privacy Statement

.

Related Tickers

AVI BioPharma, Inc.

AVII Down! $0.90 -0.02 (-2.17%) 3:59 PM
CAPS Rating:
83 Outperforms
10 Underperforms
Rate This Stock

Major Indices

S&P 500899.22 -1.18%
DJIA8,451.19 -1.49%
NASD1,649.51+0.27%
Updated: 4:09:31 PM
Sponsored by:

The Motley Poll

What do you think will be the best performing sector over the next six months?

Sponsored by: